WATERS CORP /DE/ is 9.6x more valuable than 10x Genomics, Inc. by market capitalization ($35.66 B vs $3.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TXG | WAT |
|---|---|---|
| Market cap | $3.72 B | $35.66 B |
| US-listed rank | #1634 | #415 |
| Revenue (latest FY) | $642.82M | $3.17B |
| Net income (latest FY) | -$43.50M | $642.63M |
| Net margin | -6.8% | 20.3% |
| P/E (trailing FY) | - | 55.5 |
| SEC filings | 652 | 1,887 |
WATERS CORP /DE/ is 9.6x more valuable than 10x Genomics, Inc. by market capitalization ($35.66 B vs $3.72 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while WATERS CORP /DE/ reported $3.17B.
Full pages: 10x Genomics, Inc. and WATERS CORP /DE/, or browse the full rankings.